Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-a) and essential hypertension
|
|
- Sherman Merritt
- 6 years ago
- Views:
Transcription
1 (2005) 19, & 2005 Nature Publishing Group All rights reserved /05 $ ORIGINAL ARTICLE Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-a) and essential hypertension LE Bautista 1,2, LM Vera 3, IA Arenas 4 and G Gamarra 3 1 Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA; 2 Department of Population Health Sciences, University of Wisconsin, Madison, WI, USA; 3 Centro de Investigación Epidemiológica, Universidad Industrial de Santander, Bucaramanga, Colombia; 4 Department of Physiology, University of Alberta, Edmonton, Alberta, Canada High blood pressure (HBP) has been associated with elevated C-reactive protein (CRP), a marker of chronic mild inflammation. However, the association between HBP and other inflammatory markers, particularly interleukin 6 (IL-6) and tumour necrosis alpha (TNF-a), has not been evaluated in well-controlled studies. We examined the cross-sectional relationship between IL- 6, TNF-a, and CRP and HBP in a random sample of 196 healthy subjects. All markers were measured in duplicate with high-sensitivity ELISA tests. Three blood pressure (BP) measurments were averaged for the analysis, and subjects with systolic BP X140 and/or diastolic BP X90 mmhg were considered hypertensive. Log binomial regression was used to estimate multivariate-adjusted prevalence ratios (PR) of HBP. Of the subjects, 40% (79) were hypertensive (mean age: 44 years; range 30 64). After adjustment for age, sex, body mass index, family history of HBP, and the level of the other inflammatory markers, subjects in the second (PR: 3.10, P ¼ 0.003), third (PR: 2.32; P ¼ 0.031), and fourth quartiles (PR: 2.30; P ¼ 0.036) of IL-6 were more than twice as likely to be hypertensive than those in the first quartile. Corresponding PR estimates for TNF-a levels were 1.41 (P ¼ 0.014) for the second; 1.59 (P ¼ 0.001) for the third; and 1.61 (P ¼ 0.025) for the fourth quartile. The CRP HBP association was not statistically significant. Our results suggest that TNF-a and IL-6 could be independent risk factors for HBP in apparently healthy subjects. Nevertheless, the temporal relationship between elevated inflammation markers and HBP should be ascertained in prospective cohort studies. (2005) 19, doi: /sj.jhh Published online 9 September 2004 Keywords: blood pressure; C-reactive protein; TNF-a; interleukin-6; risk factors Introduction High blood pressure (HBP) is one of the most important risk factors for cardiovascular renal disease. In spite of its high health impact, primary prevention of HBP is partly hampered because of a limited knowledge of HBP risk factors. Several prospective cohort studies have shown that acute systemic inflammation is associated with an increased risk of acute cardiovascular events 1 3 and cardiovascular mortality. 4,5 Recently published data also suggest that chronic inflammation could be an Correspondence: Dr LE Bautista, University of Wisconsin Medical School, Population Health Sciences, 610 Walnut Street, 703 WARF, Madison, WI , USA. lebautista@wisc.edu Received 16 April 2004; revised and accepted 1 August 2004; published online 9 September 2004 independent risk factor for HBP. C-reactive protein has been shown to be associated to HBP in a few well-controlled studies. 6 8 On the other hand, results from studies on the association between interleukin-6 (IL-6) and HBP have been contradictory. 9,10 Similarly, some studies in human subjects have shown a positive association between tumour necrosis factor alpha (TNF-a) level and HBP, 11,12 but others have not. 13,14 However, most of these studies were not designed to test the association between inflammation markers and HBP and have failed to control for other risk factors for HBP and for other inflammatory markers. Since C- reactive protein (CRP) production by hepatocytes is regulated by cytokines, mostly IL-6 and TNF-a, 15 it is unlikely that any one inflammatory marker will fully reflect the complexity of mild chronic inflammation and capture its relationship with HBP. Moreover, the effect of one cytokine on HBP may
2 150 be confounded or interact with the effects of the other cytokines, a problem that has not been addressed in previous studies. In this article, we report the independent effects of CRP, TNF-a, and IL-6 on blood pressure (BP) in a random sample of free-living healthy subjects. Methods Inflammatory markers and hypertension We studied a group of subjects who participated in a previous cross-sectional study of cardiovascular risk factors conducted in a random sample of free living, apparently healthy subjects from Bucaramanga, Colombia. 16 Participants X30 and o65 years old were randomly selected from an original sampling frame of 2432 participants. The study was approved by the IRB of the Universidad Industrial de Santander and written informed consent was obtained from all subjects. All subjects completed an interview aimed to ascertain cardiovascular risk factors, history of coronary heart disease, and medication used. Anthropometric measurements were carried out by duplicate and the mean of the two measurements was used during the analysis. BP was measured in the seated position, in the right arm, after a 5-min rest period, following the recommendations of the American Heart Association. 17 The average of three consecutive BP measurements, taken by two independent observers, was used as the BP value in this report. Hypertension was defined as a systolic BP X140 mmhg and/or a diastolic BP X90 mmhg, or current treatment with antihypertensive medication. Stored blood samples were tested for levels of CRP, IL-6, and TNF-a. None of the participants had any febrile illness or major trauma during the 15 days before enrollment. High-sensitivity ELISA tests for CRP, IL-6, and TNF-a were conducted in duplicate using the IMMULITE Automated Analyzer and kits (Diagnostic Products Corporation, Los Angeles, CA, USA). The CRP, IL-6 and TNF-a tests have limits of detection of 0.01 mg/dl, 5, and 1.7 pg/ml, respectively. To account for their positive skewness, values of CRP, TNF-a, and IL-6 were transformed and analysed in the natural log scale. We used censored-normal regression to estimate the mean and standard deviation of TNF-a and IL-6, while taking in consideration the presence of values below the limit of detection of the tests. Log normality of nontruncated values was graphically confirmed. Exposure groups were defined using quartiles of the observed distribution of each inflammatory marker in the group of nonhypertensive subjects. The groups so-defined were compared regarding the prevalence of HBP. We used log binomial regression 18 to calculate prevalence ratios of HBP, taking the lowest quartile of each marker as the reference group. Log binomial regression allows the estimation of the prevalence ratio instead of the prevalence odds ratio, usually obtained from logistic regression models. Contrary to the odds ratio, the prevalence ratio (PR) does not overestimate the effect of the exposure for conditions with a high prevalence, such as HBP. Age, sex, body mass index, plasma cholesterol and triglyceride levels, smoking, history of hypertension in a parent or sibling, diabetes, and use of drugs that could have affected plasma levels of inflammatory makers in the last 2 weeks were evaluated as potential confounders of the association between HBP and each inflammatory marker. Only those variables significantly associated to HBP and those that qualified as confounders were retained in the final models. 19 The overall fitness of the final regression model was evaluated using Tsiatis test. 20 Results A total of 79 out of 205 hypertensive and 117 out of 2227 nonhypertensive subjects were randomly selected and included in the study. The average age was 44 years (range: 30 64) and 37% were male. As expected, hypertensives were significantly older, had significantly higher body mass index, and were more likely to have a close relative with diagnosed hypertension than nonhypertensives (Table 1). Plasma glycaemia, cholesterol, and triglycerides were also considerably higher among hypertensives. IL-6 plasma levels were below the limit of detection of the test in 29 (15.4%) of the subjects. Similarly, 88 subjects (46.6%) had TNF-a levels below the limit of detection. Plasma levels of IL-6 and TNF-a were two to four times higher in subjects with HBP (P-values: and 0.015; Table 1). However, both groups had similar levels of plasma CRP (P ¼ 0.564). A small group of 23 subjects had received drugs that could have affected the concentration of plasma cytokines (anti-inflammatory drugs, statins, and glitazones). Levels of CRP, TNFa, and IL-6 were not significantly different among these subjects (P ¼ 0.80, 0.17, and 0.71, respectively). HBP prevalence increased progressively from 30.4% in the first (lowest) to 52.8% in the fourth (highest) quartile of TNF-a. This corresponded to a PR of 1.73 (95% CI: 1.10, 5.50; Table 2). A significant increase in HBP prevalence was also observed in subjects in the second to fourth quartiles of IL-6, as compared to those in the first quartile. Subjects in the second quartile of IL-6 were 2.95 times more likely to be hypertensive than those in the first quartile (P ¼ 0.006). Subjects in the third (PR: 2.64; P ¼ 0.017) and fourth quartiles of IL-6 (PR: 2.47; P ¼ 0.027) also had a significantly higher prevalence of HBP than those in the first quartile. Nevertheless, the relative effect of IL-6 on HBP prevalence decreased beyond the second quartile. A similar pattern was observed for quartiles of CRP, with a borderline significant PR for the second quartile (PR:
3 Inflammatory markers and hypertension Table 1 Mean values of cardiovascular risk factors by hypertension status 151 Risk factor Hypertensive (n ¼ 79) mean (95% CI) a Nonhypertensive All (n ¼ 196) Mean P-value* (n ¼ 117) Mean (95% CI) a (95% CI) a Age (years) 46.6 (44.4, 48.9) 41.8 (40.3, 43.3) 43.7 (42.4, 45.0) o0.001 Male (%) 36.7 (26.1, 48.3) 36.8 (28.0, 46.2) 36.7 (30.0, 43.9) Systolic BP (137.2, 147.3) (106.6, 111.4) (119.0, 125.8) o0.001 Diastolic BP 87.1 (84.4, 89.8) 71.6 (70.1, 73.2) 77.9 (76.1, 79.6) o0.001 BMI b 27.8 (26.6, 28.9) 25.2 (24.4, 26.1) 26.3 (25.6, 27.0) o0.001 Glycaemia (mg/dl) 89.6 (85.8, 93.4) 85.8 (83.3, 88.2) 87.3 (85.2, 89.4) 0.09 Cholesterol c Total (218.9, 237.4) (205.4, 221.2) (213.3, 225.3) HDL 42.8 (40.8, 44.8) 41.5 (39.8, 43.1) 42.0 (40.7, 43.3) LDL (138.6, 156.7) (132.2, 146.5) (137.0, 148.2) Triglycerides c (176.1, 229.0) (149.6, 191.8) (167.0, 200.0) Smokers (%) 15.4 (9.4, 23.2) 16.5 (9.1, 26.5) 15.8 (11.0, 21.7) 0.84 Relative with HBP d (%) 72.2 (60.9, 81.6) 57.0 (47.4, 66.2) 63.2 (56.0, 70.0) Diabetes (%) 5.1 (1.4, 12.5) 2.5 (0.5, 7.3) 3.6 (1.4, 7.2) IL-6 (pg/ml) 10.0 (7.9, 12.6) 5.0 (3.5, 6.9) 6.8 (5.5, 8.4) TNF-a (pg/dl) 7.9 (4.2, 15.0) 1.8 (0.8, 4.0) 3.5 (2.1, 5.8) CRP e (mg/dl) 0.29 (0.23, 0.36) 0.26 (0.22, 0.32) 0.27 (0.24, 8.37) a 95% confidence interval. b Body mass index (kg/m 2 ). c mg/ml. d Parent or sibling with high blood pressure. e C-reactive protein. *Hypertensive vs non-hypertensive. Table 2 Prevalence and PR of HBP by quartiles of inflammatory marker Quartiles of inflammatory marker Prevalence cases (%) PR (95% CI) P-value IL-6 (pg/ml) p p , o12.4 p , , TNF-a (pg/dl) p p , p , , CRP (mg/dl) p p , p , , ; P ¼ 0.051) and nonsignificant and smaller increases in the third and fourth quartiles. Adjustment by age and sex changed little the pattern of associations observed in the crude analysis, with the exception of a higher PR for the second quartile of TNF-a (PR: 1.65; P ¼ 0.004; Table 2). In a multivariate analysis, age, sex, body mass index, and a history of HBP in a close relative were the only variables retained in the model as independent risk factors or as confounding variables. After adjustment for these variables, IL-6, and TNF-a plasma levels were significantly associated with increased prevalence of HBP. Subjects in the second to fourth quartiles of IL-6 were at least twice more likely to be hypertensive than those in the lowest quartile (Table 3). Similarly, participants with TNF-a level in the second to fourth quartile were roughly 1.5 times more likely to have HBP than those in the lowest quartile. On the contrary, there was no significant association between CRP level and HBP prevalence. In a final model we included all three inflammatory markers and the above-mentioned confounding factors. According to this model, the prevalence of HBP was 3.10 times higher in subjects in the second quartile of IL-6 (P ¼ 0.003), 2.32 times higher in those in the third quartile (P ¼ 0.031), and 2.30 times higher in those in the fourth quartile (P ¼ 0.036), as compared to those in the first quartile (Table 4). Similarly, HBP prevalence increased 1.41 times (P ¼ 0.014) in the second quartile of TNF-a, 1.59 times in the third quartile (P ¼ 0.001), and 1.61 times in the fourth quartile (Po0.001), as compared to the prevalence in the first quartile. On the other hand, PRs of HBP were nonsignificant in subjects in the third and fourth quartiles and only marginally significant in the second quartile of CRP (PR: 1.30; P ¼ 0.052), as compared to subjects in the first quartile. An evaluation of goodness-of-fit showed that our model was a good representation of the data, since expected case and control counts predicted by the model were not statistically different from observed counts (P ¼ 0.14). Finally, we added interaction terms to our model in order to test whether the effect of a maker (eg IL-6) on HBP prevalence depended on the level of the other markers (eg CRP). This analysis showed no
4 Inflammatory markers and hypertension 152 Table 3 PR of HBP by quartiles of inflammatory marker, adjusted by age and sex and by traditional cardiovascular risk factors Quartiles of inflammatory marker Age- and sex-adjusted Multivariate-adjusted PR a (95% CI) P-value PR b (95% CI) P-value IL-6 (pg/ml) p p (1.48, 6.49) (1.34, 5.72) p (1.19, 5.58) (1.22, 5.36) (1.14, 5.28) (1.01, 4.61) TNF-a (pg/dl) p p (1.18, 2.30) (1.02, 2.61) p (1.02, 2.45) (0.92, 2.17) (1.18, 2.30) (1.05, 2.01) CRP (mg/dl) p p (0.94, 2.70) (0.92, 1.61) p (0.65, 2.12) (0.46, 1.13) (0.71, 2.23) (0.62, 1.41) a Age- and sex-adjusted PR. b Adjusted by age, sex, body mass index and history of high blood pressure in parent or sibling. Table 4 PR of hypertension by quartiles of inflammatory marker adjusted by cardiovascular risk factors and levels of the other inflammatory markers Quartiles of inflammatory marker PR a (95% CI) P-value IL-6 (pg/ml) p p (1.47, 6.56) p (1.08, 4.99) (1.06, 4.99) TNF-a (pg/dl) p p (1.07, 1.86) p (1.21, 2.09) (1.38, 1.90) CRP (mg/dl) p p (1.00, 1.70) p (0.57, 1.27) (0.82, 1.62) a Adjusted for age, sex, body mass index, history of hypertension in parents or siblings, and levels of the other inflammatory markers. evidence of significant interaction between IL-6 and TNF-a (P ¼ 0.110), IL-6 and CRP (P ¼ 0.928), and TNF-a and CRP (P ¼ 0.769). Discussion This population-based study shows a significant association between IL-6 and TNF-a, two markers of chronic mild inflammation, and the presence of HBP among apparently healthy subjects. The prevalence of HBP increased significantly with increased level of IL-6. However, the rate of increase was higher in the lower end of the distribution of IL- 6 than in the upper end. This suggests that instead of a straight line, the HBP IL-6 relationship follows a curve that flattens out at higher values of IL-6. Nevertheless, even subjects in the upper quartile of IL-6 had a significant increase of two times the prevalence of HBP observed among those in the first quartile. Also, the prevalence of HBP increased progressively and significantly with higher levels of TNF-a, but the PR was very similar in the third and fourth quartiles of this marker. On the contrary, after adjustment for other risk factors and for IL-6 and TNF-a, CRP was not significantly associated with HBP. These results are important, as they suggest that the relationship between mild chronic inflammation and coronary heart disease 1,2 may be mediated not only through the development of the atherosclerotic plaque, but also by an increased risk of HBP. Previous studies have reported conflicting results about the relationship between IL-6 and HBP. 3,5,9,10,12,13,21,22 With one exception, 10 these studies were not designed to test the association between IL-6 and HBP, and failed to control for other cardiovascular risk factors. In fact, our results are consistent with those from the study of Chae et al, 10 the only other study in which appropriate control of confounding factors has been conducted. An association between IL-6 and BP level is biologically plausible. IL-6 stimulates the synthesis of many acute-phase reaction proteins, including CRP, 23 and counter-regulates TNF-a and interleukin- 1 b levels. 24 A common functional polymorphism of the IL-6 gene promoter region (-174 G4C) has been shown to influence levels of circulating IL-6 in vivo. 25 CC homozygous subjects seem to respond to inflammatory stimuli with a higher increase in IL Also, systolic and diastolic BP seem to be higher in healthy subjects 27 and dialysis patients 28 with the CC genotype as compared to carriers of the -174 G allele. However, Pola et al 29 failed to show and association between this polymorphism and essen-
5 Inflammatory markers and hypertension tial hypertension in a sample of 210 cases and 177 controls older than 65 years. There is also experimental evidence that IL-6 prolongs the endothelial dysfunction associated with the administration of IL-1b and TNF-a in human volunteers. 30 Therefore, IL-6 may result in elevated BP by inducing endothelial dysfunction and increasing peripheral vascular resistance. 31,32 Some reports of studies in human subjects have shown a significant association between TNF-a and elevated BP, 11,12,21 but others have failed to show such an association. 13,14 Unfortunately, none of these studies has been designed to test this hypothesis and all have failed to control for other risk factors. However, in experimental studies the degree of activation of the TNF-a system has been positively and significantly associated with systolic and diastolic BP. 33 Besides, TNF-a decreases endothelial nitric oxide synthase mrna level by shortening its half-life. 34 This may result in decreased bioavailability of nitric oxide and lead to endothelial dysfunction, chronic vasoconstriction, and elevated BP. Finally, a common polymorphism in the promoter region of the TNF-a gene has been associated to increased TNF-a and systolic BP. 35 Contrary to previous studies aimed to test this hypothesis, 6,7,36 we did not find a significant association between CRP and hypertensive status. In our analysis the effect of CRP may be absent due to the inclusion of TNF-a and IL-6 in the final model. However, CRP effects failed to be significant even when adjusting only for TNF-a, only for IL-6, or for none of them. A lack of an adequate sample size is a more likely explanation of this finding. Indeed, the confidence intervals for the PR in the third and fourth quartiles of CRP were considerably wide, reflecting lack of power. Common biases are unlikely explanations of our results. Since both cases and controls were randomly sampled from the same population, the likelihood of selection bias is very restricted. Information error was limited because the laboratory tests used to measure inflammatory markers are highly reliable, and were conducted in duplicate, without knowledge of other cardiovascular risk factors or BP status. All additional study measurements were also highly standardized and carried out by trained personnel. Under these conditions, any information error is likely to be nondifferential and would result in underestimation of the effect of the inflammatory markers. Finally, confounding factors, including the use of drugs capable of lowering plasma levels of inflammatory markers, were controlled for by means of multivariate analysis. A limitation of our study comes from the number of values of TNF-a and IL-6 values that were below the limit of detection for their corresponding tests. Although this is of no consequence for the analysis by quartiles of TNF-a and IL-6, it precludes their analysis as continuous exposures. A more relevant limitation of our study results from its crosssectional nature. Since inflammatory markers were measured at the same point in time as BP, it is not possible to know whether one precedes the other or vice versa. It is also possible that elevated TNF-a and IL-6 may both precede and follow HBP. 32 There is experimental evidence that endothelial cells exposed to the shear stress resulting from elevated BP increase their production of IL-6 and TNF-a. 37,38 Unfortunately, there are few if any human data on the effect of elevated BP on the synthesis of cytokines and CRP. We have found no changes in CRP levels in subjects with drug-controlled hypertension as compared to noncontrolled subjects, 32 which suggests that CRP levels are not a consequence of elevated BP. Since heritability seems to be an important independent determinant of the level of inflammatory markers in normal subjects, there is a real possibility that elevated inflammatory markers could precede the development of HBP, even if the inflammatory process is also a response to the elevation of the BP. Finally, high plasma levels of orosomucoid, a1-antitrypsin, haptoglobin, and ceruloplasmin, proteins that are components of the chronic inflammatory response, have been associated with future development of high BP. 39 In conclusion, our results suggest that TNF-a and IL-6 could be independent risk factors for the development of HBP in apparently healthy subjects. Nevertheless, the temporal relationship between elevated inflammation markers and elevated BP should be ascertained in prospective cohort studies. Acknowledgements This study was funded by COLCIENCIAS. References 1 Ridker PM et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: Ridker PM et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: Ridker PM et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: Harris TB et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106: Volpato S et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women s health and aging study. Circulation 2001; 103: Bautista LE et al. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19: Chul SK et al. High sensitivity c-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens 2003; 16:
6 154 Inflammatory markers and hypertension 8 Bautista LE et al. Association between C-reactive protein and hypertension in healthy middle-aged men and women. Coron Artery Dis 2004; 15 (in press). 9 Rifai N et al. Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 1999; 45: Chae CU et al. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38: Ito H et al. Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women. Clin Exp Pharmacol Physiol 2001; 28: Furumoto T et al. Association of cardiovascular risk factors and endothelial dysfunction in japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 2002; 25: Mendall MA et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997; 78: Sheu WHH et al. Plasma tumor necrosis factor alpha levels and insulin sensitivity in hypertensive subjects. Clin Exp Hypertens 2000; 22: Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: Bautista L et al. Prevalencia de Factores de Riesgo para Enfermedades Crónicas No Transmisibles en la Población de Bucaramanga. Encuesta Basal del Programa CARMEN. UIS Bucaramanga. 17 Perloff D et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 1986; 123: Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79: Tsiatis AA. A note on a goodness-of-fit test for the logistic regression model. Biometrika 1980; 67: Yudkin JS et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: Fernandez-Real JM et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86: Woods A et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin- 6. Eur Heart J 2000; 21: Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: antiinflammatory and immunosuppressive mediators. Immunol Today 1997; 18: Fishman D et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemiconset juvenile chronic arthritis. J Clin Invest 1998; 102: Brull DJ et al. The effect of the interleukin-6-174g4c promoter gene polymorphism on endothelial function in healthy volunteers. Eur J Clin Invest 2002; 32: Humphries SE et al. The interleukin G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: Losito A et al. Association of interleukin-6-174g/c promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int 2003; 64: Pola R et al. The -174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population. J Hum Hypertens 2002; 16: Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96: Hingorani AD et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: Epidemiologic and biological evidence. J Hum Hypertens 2003; 17: Fernandez-Real JM et al. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002; 282: Yoshizumi M et al. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mrna by shortening its half-life. Circ Res 1993; 73: Dalziel B et al. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 2002; 10: Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey Circulation 2003; 108: Nomura S et al. High-shear stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 2001; 158: Sterpetti AV et al. Shear stress increases the release of interleukin-1 and interleukin-6 by aortic endothelial cells. Surgery 1993; 114: Engstrom G et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2002; 22:
ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationInflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence
(2003) 17, 223 230 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh REVIEW ARTICLE Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationApelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure
Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure CI Liakos, 1 EA Sanidas, 1 DN Perrea, 1 V Gennimata, 1 V Chantziara, 1 CA Grassos, 2 N-A Viniou, 1 JD Barbetseas,
More informationPATIENTS AND METHODS:
BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret
ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as
More informationCross-sectional data have shown positive associations between
Blood Pressure Increase and Incidence of Hypertension in Relation to Inflammation-Sensitive Plasma Proteins Gunnar Engström, Lars Janzon, Göran Berglund, Peter Lind, Lars Stavenow, Bo Hedblad, Folke Lindgärde
More informationGender-specific association between pulse pressure and C-reactive protein in a Chinese population
(2005) 19, 293 299 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Gender-specific association between pulse pressure and C-reactive protein in
More informationJMSCR Volume 03 Issue 04 Page April 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Study of Metabolic Syndrome and Thyroid Dysfunction Authors Dr. Nalini R Humaney, Dr. Saurabh Ashok Lande, Dr. Ramesh P Mundle N.K.P.Salve
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More informationNon alcoholic fatty liver disease and atherosclerosis Raul Santos, MD
Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Sao Paulo Medical School Hospital Sao Paulo, Brazil Disclosure Honoraria received for consult and/or speaker : Astra Zeneca, Amgen,
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationShort stature is an inflammatory disadvantage among middle-aged Japanese men
Environ Health Prev Med (2016) 21:361 367 DOI 10.1007/s12199-016-0538-y REGULAR ARTICLE Short stature is an inflammatory disadvantage among middle-aged Japanese men Yuji Shimizu 1,2 Hiroyuki Yoshimine
More informationDecreased Inflammatory Markers in Diabetic Patients with Angiographically Proved Coronary Artery Disease after 18 Months of Statins Therapy
Decreased Inflammatory Markers in Diabetic Patients with Angiographically Proved Coronary Artery Disease after 18 Months of Statins Therapy DANIEL LIGHEZAN, ROXANA BUZAS, CORINA SERBAN, IOANA SUCEAVA University
More informationIschemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010
Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationInflammation plays a major role in atherosclerosis, 1 and
Soluble P-Selectin and the Risk of Future Cardiovascular Events Paul M. Ridker, MD; Julie E. Buring, ScD; Nader Rifai, PhD Background P-selectin, a cell-surface adhesion molecule involved in leukocyte
More informationNovel Markers of Arterial Dysfunction
혈관연구회창립심포지움, 3 월 3 일, 2005 Novel Markers of Arterial Dysfunction Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon Medical School Incheon, Korea Atherosclerosis: A progressive process PHASE I: Initiation
More informationDivision of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan
Association between continuously elevated C-reactive protein and restenosis after percutaneous coronary intervention using drug-eluting stent in angina patients Division of Cardiovascular Medicine, Jichi
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationSpotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound
Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound Department of Cardiovascular Medicine Heart and Vascular Institute
More informationFatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins
Fatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins A Population-Based Prospective Cohort Study Gunnar Engström, MD; Bo Hedblad, MD; Lars Stavenow, MD; Patrik Tydén,
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More informationENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH
ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH I Jialal, MD, PhD. FRCPath.DABCC Robert E. Stowell Chair in Experimental Pathology Professor of Pathology and Medicine Director, Laboratory
More informationModerate alcohol consumption is associated with decreased
Alcohol Consumption and Plasma Concentration of C-Reactive Protein Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Moderate alcohol intake has been associated with
More informationHIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES
HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More informationPatients with the metabolic syndrome are at increased risk
Clinical Investigation and Reports C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events An 8-Year Follow-Up of 14 719 Initially Healthy American Women Paul M Ridker, MD;
More informationSmall dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study
Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori
More informationASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION
ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION Jung-Sun Kim a and Sungha Park a,b, a Division of Cardiology, b Cardiovascular Genome Center, Yonsei Cardiovascular Center,
More informationTraditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com 1000 80 20 60 40 40 60 20 80
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationThe Relationship Between Blood Pressure and C-Reactive Protein in the Multi-Ethnic Study of Atherosclerosis (MESA)
Journal of the American College of Cardiology Vol. 46, No. 10, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.07.050
More informationHypertension is a central risk factor for cardiovascular
Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events Gavin J. Blake, MD, MPH, MRCPI; Nader Rifai, PhD; Julie E. Buring, ScD; Paul M Ridker, MD, MPH Background Accumulating data
More informationTHE C-REACTIVE PROTEIN IS A
ORIGINAL CONTRIBUTION C-Reactive Protein and the Risk of Developing Hypertension Howard D. Sesso, ScD, MPH Julie E. Buring, ScD Nader Rifai, PhD Gavin J. Blake, MD, MPH J. Michael Gaziano, MD, MPH Paul
More informationVal-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions in hs-crp
Página 1 de 5 Return to Medscape coverage of: American Society of Hypertension 21st Annual Scientific Meeting and Exposition Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions
More informationHospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension
(2003) 17, 665 670 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Hospital and 1-year outcome after acute myocardial infarction in patients with
More informationCardiovascular Risk Factors: Distribution and Prevalence in a Rural Population of Bangladesh
"Insight Heart" is also available at www.squarepharma.com.bd Cardiovascular Risk Factors: Distribution and Prevalence in a Rural Population of Bangladesh Coronary heart disease has been emerging as an
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationSupplementary Online Content
Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.
More informationFasting or non fasting?
Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics Which is best to measure Lower continues
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationSupplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups
Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate
More information10/17/16. Assessing cardiovascular risk through use of inflammation testing
Assessing cardiovascular risk through use of inflammation testing Anthony L. Lyssy, DO Medical Director and Managing Partner Diamond Physicians Dallas, TX Response to Injury Hypothesis Injury Response
More informationORIGINAL ARTICLE SUMMARY
ORIGINAL ARTICLE HIP CIRCUMFERENCE IS AN IMPORTANT PREDICTOR OF PLASMA C-REACTIVE PROTEIN LEVELS IN OVERWEIGHT AND OBESE TAIWANESE WOMEN Hei-Jen Jou 1,2, I-Ping Hsu 3, Pei-Ying Ling 1, Chia-Tzu Lin 1,
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationProven and Proposed Cardiovascular Benefits of Soyfoods
Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationObesity Associated Inflammation in African American Adolescents and Adults
CLINICAL INVESTIGATION Obesity Associated Inflammation in African American Adolescents and Adults Stephanie DeLoach, MD, Scott W. Keith, PhD, Samuel S. Gidding, MD and Bonita Falkner, MD Abstract: Background:
More informationBy: Dr Mehrnoosh Shanaki
Resveratrol could partly improve the crosstalk between canonical β-catenin/wnt and FOXO pathways in coronary artery disease patients with metabolic syndrome: A case control study By: Dr Mehrnoosh Shanaki
More informationImpact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography
Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationInflammation, as Measured by the Erythrocyte Sedimentation Rate, Is an Independent Predictor for the Development of Heart Failure
Journal of the American College of Cardiology Vol. 45, No. 11, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.02.066
More informationRelation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population
(2003) 17, 555 559 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood
More information902 Biomed Environ Sci, 2014; 27(11):
902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type
More informationPart 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD
Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationDyslipidemia, hypertension, smoking, and diabetes are
Inflammation-Sensitive Plasma Proteins and Incidence of Myocardial Infarction in Men With Low Cardiovascular Risk Gunnar Engström, Lars Stavenow, Bo Hedblad, Peter Lind, Patrik Tydén, Lars Janzon, Folke
More informationFrequency of Dyslipidemia and IHD in IGT Patients
Frequency of Dyslipidemia and IHD in IGT Patients *Islam MS, 1 Hossain MZ, 2 Talukder SK, 3 Elahi MM, 4 Mondal RN 5 Impaired glucose tolerance (IGT) is often associated with macrovascular complications.
More informationJournal of the American College of Cardiology Vol. 37, No. 8, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 8, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01289-X Coronary
More informationORIGINAL ARTICLES. Associations between body mass index and serum levels of C-reactive protein. Materials and methods.
Associations between body mass index and serum levels of C-reactive protein Tung-Wei Kao, I-Shu Lu, Kuo-Chen Liao, Hsiu-Yun Lai, Ching-Hui Loh, Hsu-Ko Kuo Background. Obesity leads to increased risk of
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationHans Strijdom SA Heart Meeting November 2017
Hans Strijdom SA Heart Meeting November 2017 HIV-infection and ART, but not high sensitivity CRP, are associated with markers of vascular function: Results from the Western Cape cohort of the EndoAfrica
More informationDiabetologia 9 Springer-Verlag 1991
Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease
More informationATHEROSCLEROTIC cardiovascular complications are the leading cause of. Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease
Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease To Decrease Plasma Adiponectin Levels Kuei-Chuan CHAN, 1 MD, Hsi-Hsien CHOU, 1 PhD, Der-Jinn WU, 1 PhD, Yi-Liang WU, 1 MD, and Chien-Ning
More informationMagnesium intake and serum C-reactive protein levels in children
Magnesium Research 2007; 20 (1): 32-6 ORIGINAL ARTICLE Magnesium intake and serum C-reactive protein levels in children Dana E. King, Arch G. Mainous III, Mark E. Geesey, Tina Ellis Department of Family
More informationThe inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema
The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,
More informationCardiovascular disease and diabetes Vascular harmony
Cardiovascular disease and diabetes 2018 Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL A Meta-analysis of LDL-C, non-hdl-c, and apob as markers of cardiovascular risk. Slide # Contents 2 Table A1. List of candidate reports 8 Table A2. List of covariates/model adjustments
More informationPrognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice
(2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and
More informationResearch Article Comparison of Different Anthropometric Measurements and Inflammatory Biomarkers
International Inflammation Volume 2012, Article ID 124693, 5 pages doi:10.1155/2012/124693 Research Article Comparison of Different Anthropometric Measurements and Inflammatory Biomarkers Yaron Arbel,
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationOverview of effects of alcohol intake on cardiovascular disease
Beverage specific effects Overview of effects of alcohol intake on cardiovascular disease Dr. Ramon Estruch Department of Internal Medicine, Barcelona University, Spain. CIBER OBN Institute of Health Carlos
More informationCoronary artery disease (CAD) risk factors
Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes
More informationEchocardiography analysis in renal transplant recipients
Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical
More informationTable S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis
SUPPLEMENTARY MATERIAL TEXT Text S1. Multiple imputation TABLES Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis Table S2. List of drugs included as immunosuppressant
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More information4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for
+ Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationPredicting failure to follow-up screened high blood pressure in Japan: a cohort study
Journal of Public Health Vol. 37, No. 3, pp. 498 505 doi:10.1093/pubmed/fdu056 Advance Access Publication August 7, 2014 Predicting failure to follow-up screened high blood pressure in Japan: a cohort
More informationATEF ELBAHRY,FACA,FICA,MISCP,FVBWG.
Hyperglycemia and Coronary Events: where is the link? ATEF ELBAHRY,FACA,FICA,MISCP,FVBWG. Cardiovascular (CV) disease is the primary complication of diabetes ~65% of deaths are due to CV disease Coronary
More informationOf the 1.5 million heart attacks
CARDIOLOGY PATIENT PAGE CARDIOLOGY PATIENT PAGE C-Reactive Protein A Simple Test to Help Predict Risk of Heart Attack and Stroke Paul M Ridker, MD, MPH Of the 1.5 million heart attacks and 600 000 strokes
More informationTestosterone Therapy in Men An update
Testosterone Therapy in Men An update SANDEEP DHINDSA Associate Professor of Medicine Director, Division of Endocrinology and Metabolism, Saint Louis University, St. Louis, MO Presenter Disclosure None
More informationThe Framingham Risk Score (FRS) is widely recommended
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore
More informationContents. I. CV disease and insulin resistance: Challenges and opportunities. II. Insulin sensitizers: Surrogate and clinical outcomes studies
Contents I. CV disease and insulin resistance: Challenges and opportunities II. Insulin sensitizers: Surrogate and clinical outcomes studies IV. Identifying and treating patients with insulin resistance
More informationAssociation between serum IGF-1 and diabetes mellitus among US adults
Diabetes Care Publish Ahead of Print, published online July 16, 2010 Association between serum IGF-1 and diabetes mellitus among US adults Running title: Serum IGF-1 and diabetes mellitus Srinivas Teppala
More informationTable 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use
Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)
More informationΛΟΙΜΩΞΗ HIV. Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική
ΛΟΙΜΩΞΗ HIV Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική Κλινική, Νοσοκομείο «Αττικόν» Infection Acute Myocardial Infarction p er 100,000 HIV/AIDS discharg es 800 700 600 500 400 300 200
More informationClinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm
Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm Department of Cardiology Keiji Inoue Akira Ueoka, Naoki Maruyama, Yoshiaki Shimoda, Eigo Kishita,
More informationEpidemiologic and clinical comparison of renal artery stenosis in black patients and white patients
ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,
More information